Skip to content

Study · Measured the body's own peptide · 1992

1 result

[Demonstration of delta sleep inducing peptide in a strain of human small cell lung cancer by immunocytology].

Paulin C, Charnay Y

Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie1 Jan 1992Cited by 1 (Europe PMC)

PMID1318772 (opens in a new tab)PepBankPUB-01318772
Publisher pageAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01LabEndogenous levelIn vitro (cells)Other

    In a strain of human small cell lung carcinoma, immunocytology with a monoclonal antibody showed DSIP-like immunoreactivity in the cells.

    In plain wordsIn cells from a human small cell lung cancer strain, the body's own DSIP-like material was detected.

    Peptide
    Delta sleep-inducing peptide (DSIP)
    Outcome
    Not applicableDSIP-like immunoreactivity in small cell carcinoma cells
    Study

    humann: not reported in source

    Small cell lung carcinoma strain
    Outcome group
    Endogenous peptide levels · Cancer

    Source sentences

    Summary
    The present immunological study, performed with a monoclonal antibody to DSIP, provides evidence for the presence of DSIP-like immunoreactivity (DSIP-LI) in a strain of small cell carcinoma.

    This result measures the body's own Delta sleep-inducing peptide (DSIP). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 17:28 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 03:04 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.